[PDF] Top 20 Comparison of Clinical Performance of Abbott RealTime High Risk HPV Test with That of Hybrid Capture 2 Assay in a Screening Setting
Has 10000 "Comparison of Clinical Performance of Abbott RealTime High Risk HPV Test with That of Hybrid Capture 2 Assay in a Screening Setting" found on our website. Below are the top 20 most common "Comparison of Clinical Performance of Abbott RealTime High Risk HPV Test with That of Hybrid Capture 2 Assay in a Screening Setting".
Comparison of Clinical Performance of Abbott RealTime High Risk HPV Test with That of Hybrid Capture 2 Assay in a Screening Setting
... of screening with human papillomavirus (HPV) DNA tests in reducing cervical cancer incidence and ...the clinical performance and reproducibility of the Abbott RealTime ... See full document
6
Comparison of Clinical and Analytical Performance of the Abbott RealTime High Risk HPV Test to the Performance of Hybrid Capture 2 in Population Based Cervical Cancer Screening
... next-generation HPV assay designed to detect a pool of 12 carcinogenic HPV genotypes in aggregate, with concurrent, separate detection of HPV16 and ...the clinical performance of ... See full document
9
Cross Sectional Comparison of an Automated Hybrid Capture 2 Assay and the Consensus GP5+/6+ PCR Method in a Population Based Cervical Screening Program
... study, clinical performances of the hybrid capture 2 assay using an automated instrument ...rapid capture system) (hc2-RCS) and the high-risk human papillomavirus ... See full document
6
Study based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens
... cytological screening in Germany in 1971 the cervical cancer mor- tality rate has notably decreased ...with High-Risk Human Papillomavi- ruses (HR HPV) is a necessary risk factor for ... See full document
9
Performance of the Aptima High Risk Human Papillomavirus mRNA Assay in a Referral Population in Comparison with Hybrid Capture 2 and Cytology
... (Pap) test (cervical cytology) has significantly reduced mortal- ity due to cervical cancer when utilized in organized screening ...Pap test has a relatively low sensitivity (51 to 74% depending on ... See full document
6
Comparison of the Digene Hybrid Capture 2 Assay and Roche AMPLICOR and LINEAR ARRAY Human Papillomavirus (HPV) Tests in Detecting High Risk HPV Genotypes in Specimens from Women with Previous Abnormal Pap Smear Results
... persistent high-risk (HR) human papillomavirus (HPV) ...(LA) HPV tests have become available for HPV ...their clinical performance compared to the ... See full document
8
Comparison of the cobas Human Papillomavirus (HPV) Test with the Hybrid Capture 2 and Linear Array HPV DNA Tests
... of high-risk genotypes of the human papillomavirus (HR-HPV) is currently used as an adjunct to cervical cytology for general ...differentiating HPV-positive, cytology-negative women at higher ... See full document
5
Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions
... and clinical performance validation is essential before introduction of a new human papillomavirus (HPV) assay into clinical ...Onclarity HPV assay, which detects E6/E7 ... See full document
6
Comparison between Prototype Hybrid Capture 3 and Hybrid Capture 2 Human Papillomavirus DNA Assays for Detection of High Grade Cervical Intraepithelial Neoplasia and Cancer
... demonstrated test positivity for untargeted HPV types 53, 66, 67, and 71 as well as occasional test positivity to other untargeted HPV types (3, 11, 19); the impact of the test ... See full document
9
Comparison of the Third Wave Invader Human Papillomavirus (HPV) Assay and the Digene HPV Hybrid Capture 2 Assay for Detection of High Risk HPV DNA
... cytologic screening programs are employed that facilitate the detection and treatment of precancerous lesions ...Pap test (4, 12, ...of high-grade squamous intraepithelial lesions cannot be excluded, ... See full document
6
Comparison of the Digene HC2 Assay and the Roche AMPLICOR Human Papillomavirus (HPV) Test for Detection of High Risk HPV Genotypes in Cervical Samples
... AMPLICOR HPV test gave a significantly higher number of positive results in this group of women, probably reflecting the higher sensi- ...AMPLICOR HPV test is used in the screening ... See full document
6
Human papillomavirus detection using the Abbott RealTime high risk HPV tests compared with conventional nested PCR coupled to high throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population
... recommend HPV DNA testing instead of cytology to carry out triage in a screened ...for HPV de- tection may be a good alternative to cytology for early screening because an HPV-negative result ... See full document
8
Clinical Performance of the PreTect HPV Proofer E6/E7 mRNA Assay in Comparison with That of the Hybrid Capture 2 Test for Identification of Women at Risk of Cervical Cancer
... higher clinical sensitivity than cytology for the detection of high-grade cervical intraepithelial neoplasia or worse (CIN 2 ⴙ ...by HPV E6/E7 oncogenes, detection of E6/E7 oncogene activity ... See full document
7
Comparison of the Abbott RealTime High Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 Assays to Direct Sequencing and Genotyping of HPV DNA
... Samples. Cervical swab specimens, which were obtained for cytologic exam, were collected from a total of 356 women at Severance Hospital and Green Cross Reference Laboratory between August and October 2011. All specimens ... See full document
7
Head to Head Comparison of the RNA Based Aptima Human Papillomavirus (HPV) Assay and the DNA Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany
... with high-risk (HR) human papillomavirus (HPV) might improve the specificity of HPV testing for the identification of cervical precancerous ...Aptima HPV (AHPV) as- say (Hologic) and ... See full document
8
Comparison of the Abbott RealTime Human Immunodeficiency Virus Type 1 (HIV 1) Assay to the Cobas AmpliPrep/Cobas TaqMan HIV 1 Test: Workflow, Reliability, and Direct Costs
... ART assay protocol requires centrifugation of all specimen tubes prior to processing by the m2000sp instrument, thus making it impractical for clinical laboratories receiving speci- men collection tubes of ... See full document
7
Comparison of Human Papillomavirus Detection by Aptima HPV and cobas HPV Tests in a Population of Women Referred for Colposcopy following Detection of Atypical Squamous Cells of Undetermined Significance by Pap Cytology
... baseline screening exami- nation, which is not the intended use ...for screening women in conjunction with cytology and immediate triage of an ASC-US Pap result to decide who needs ...the test ... See full document
5
Clinical validation of the HPVIR high risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening
... PCR test, detecting and quantifying HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59 ...The clinical material applied to this card is stable at room temperature and samples stored on FTA cards for 1 ... See full document
7
Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women
... under high-stringency conditions with a mixture of RNA probes that detect 13 different oncogenic HPV genotypes: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and ... See full document
7
A Comparison of the performance of Invasive Tests for Genetic Congenital Defects in Response of the First- Trimester Screening with High and High Moderate Risks
... in high-risk and high-moderate risk groups, 99 persons were selected ...with high risk were those with a risk below 1/50 and women at high-moderate risk were ... See full document
7
Related subjects